Loading people...
Gaurav Tuli is a Partner at F-Prime Capital Partners, a venture capital firm. He is an experienced investor specializing in enterprise software, fintech, and healthcare IT, bringing a strong background in growth-stage software investments and investment banking.
Gaurav Tuli primarily invests in companies within the enterprise software, financial technology (fintech), healthcare IT, digital health, and tech-enabled services sectors. He seeks out innovative companies with strong growth potential and disruptive technologies.
Gaurav Tuli works as a Partner at F-Prime Capital Partners, a global venture capital firm. He joined the firm in 2017 and plays a key role in their investment activities.
Gaurav Tuli is a Partner at F-Prime Capital Partners, the venture capital arm of Fidelity Investments, based in the Greater Boston Area. Before assuming his current role in January 2016, he served as a Principal at Eight Roads and worked as the Director of Product Management at Castlight Health. He previously held research and consulting positions at The Advisory Board Company and earned an MBA from Harvard Business School. As an investor, Tuli has backed numerous high-growth companies, including participating in a $105 million Series D funding round for Innovaccer and supporting Threat Stack before its acquisition by F5 Networks. His portfolio also includes successful enterprises like PatientPing, which was acquired by Appriss Health in 2021, alongside Flywire and Toast. Tuli currently focuses on scaling early-stage digital health platforms, value-based care models, and enterprise healthcare IT solutions.
Gaurav Tuli serves as a distinguished Partner at F-Prime Capital Partners, a global venture capital firm renowned for backing groundbreaking companies. In his pivotal role, Tuli is instrumental in leading investments across several high-growth sectors, primarily focusing on enterprise software, financial technology (fintech), healthcare IT, digital health, and tech-enabled services. His expertise lies in identifying visionary entrepreneurs and disruptive technologies that are poised to redefine their respective industries, guiding them from early-stage development through significant growth and market leadership.
Tuli's investment philosophy is deeply rooted in understanding market dynamics and technological innovation. He actively partners with management teams, providing strategic guidance and leveraging F-Prime's extensive network to accelerate growth and achieve successful outcomes. His portfolio reflects a keen eye for companies that deliver tangible value and possess strong potential for scalability. Notable investments where Tuli has played a key role include Flywire (NASDAQ: FLYW), a leading global payments platform; Flexport, a modern freight forwarder; Mulesoft (acquired by Salesforce), an integration software provider; Cloudmed (acquired by R1 RCM), a revenue intelligence platform for healthcare; Lumere (acquired by GHX), a healthcare data analytics firm; PatientPing (acquired by Appriss Health), focused on care coordination; and Wellframe (acquired by HealthEdge), a digital health management solution. These examples underscore his ability to identify and nurture companies that achieve significant market impact and successful exits.
Before joining F-Prime Capital Partners in 2017, Tuli honed his investment acumen at Insight Partners, a prominent private equity and venture capital firm specializing in growth-stage software companies. During his tenure there, he gained invaluable experience in evaluating and supporting high-potential software businesses. Prior to his venture capital career, Tuli worked in investment banking at Credit Suisse, where he was part of the Technology, Media, and Telecommunications (TMT) group. This background provided him with a strong foundation in financial analysis and strategic advisory, which he now applies to his venture investments.
Academically, Gaurav Tuli holds an MBA from the Wharton School at the University of Pennsylvania. He also earned a Bachelor of Science in Economics from the Wharton School and a Bachelor of Arts in International Studies from the University of Pennsylvania, demonstrating a diverse and robust educational background. His comprehensive experience, spanning investment banking, growth equity, and venture capital, positions him as a highly effective and respected investor within the F-Prime Capital Partners team and the broader technology and healthcare investment landscape.
